|
COPYRIGHT 2006 Society for the Advancement of Education
Scientists have completed the first human clinical trial of a recombinant vaccine for the deadly toxin ricin--a potential bioterror threat--and the results indicate it is safe and effective in eliciting ricin-neutralizing antibodies, report researchers from the University of Texas Southwestern Medical Center, Dallas.
"Our major concern in this trial...
Read the full article for free courtesy of your local library.
|